Investors pump another $8.8M into KC medical device startup, bringing funding total to $20M+
March 31, 2020 | Startland News Staff
A Fairway-based medical device company is getting to the heart of its entrepreneurial journey, securing a fresh $8.8 million in Series A financing, Dr. Nicholas Franano announced Tuesday.
The additional influx to Artio — rebranded from “Metactive” earlier this winter — brings the startup’s total capital raised to more than $20 million. The company has spent years developing groundbreaking, best-in-class products for the peripheral vascular and neurovascular markets, said Franano, founder, president and CEO of Artio.
“We appreciate the strong support from our new and existing investors,” he said. “Our team is looking forward to making our innovative products available to physicians and patients.”
Click here to see why Artio/Metactive was named one of Startland News’ Kansas City Startups to Watch in 2019.
Funds from the latest round are expected to help Artio obtain 510(k) marketing clearance from the U.S. Food and Drug Administration (FDA) to market its Solus Gold Embolization Device in the United States.
Solus Gold Embolization Device
The Solus Gold is the first metal implant to provide a solid barrier to blood flow, and is developed for peripheral vascular embolization — a minimally invasive procedure that blocks or reduces blood flow in blood vessels for patients experiencing life-threatening bleeding and other serious medical conditions.
The combination of a low-profile, flexible delivery system and a detachable gold metal implant is designed for passage through tortuous blood vessels, precision placement, and immediate vessel occlusion after placement of a single device, according to the company.
Franano’s team also has revealed two other next-gen embolization products, the Solus Flex device and Aneura system.
Click here to learn more about these peripheral vascular solutions.
“Artio is developing a strong portfolio of disruptive, next-generation peripheral vascular and neurovascular embolization products, and we were thrilled to help lead the latest round of funding,” said Nathaniel Hagedorn, founder and CEO of Northpoint Development. “I have been incredibly fortunate to have so many people help me build my business and am happy to ‘pay it forward’ to a fellow entrepreneur with a clear vision and accomplished team.”
Featured Business
2020 Startups to Watch
stats here
Related Posts on Startland News
Google Fiber hops to new, pricier plans for businesses
All good things — or in this case inexpensive things — must come to an end. Google Fiber will soon nix early-access pricing for its gigabit business service and will more than double its costs for new customers in August. Google Fiber — which first arrived in Kansas City in 2012 with residential service —…
Amazon to bring 1,000 jobs, huge facility to KCK
Online retail giant Amazon will open a massive new facility in Kansas City, Kan. The Seattle-based company announced Monday that it will create more than 1,000 full-time jobs and construct an 855,000-square-foot fulfillment facility near the Turner Diagonal on I-70 in Kansas City, Kan. “These aren’t just any jobs. They are the best entry-level jobs our…
Survey: KC is sticky for startups with equity funding
A majority of Kansas City startups choose to maintain their hometown roots after they raise capital — even when the funds come from outside investors, a recent survey found. Of the companies that raised money in 2013 and 2014, 74 percent of them are still active and headquartered in the City of Fountains, according to…
A marriage of Mr. K’s passions, ‘E Day at the K’ returns July 19
To say one of Kansas City’s greatest entrepreneurs — Ewing Marion Kauffman — loved baseball would be an understatement. The founder of Marion Laboratories Inc., Kauffman purchased the Royals in 1968 to bring America’s pastime to his beloved hometown, Kansas City. Along with boosting civic pride, the Royals became a model franchise, employing “moneyball” statistical…